Globe Life

GL · NYSE

$169.72+$1.87 (+1.11%)TodayMarket closed ·
Prev close $167.85

About GL

Globe Life, Inc. is an insurance holding company, which engages in the provision of individual life and supplemental health insurance products and services. The company is headquartered in Mckinney, Texas and currently employs 3,695 full-time employees. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company’s segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The firm offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare.

Employees
3,695
Headquarters
McKinney, Texas
Listed
Dec 31, 1980
Sector
Financials
Industry
Insurance

GL key statistics

Market cap
12.90B
Price-earnings ratio
11.14
Dividend yield
0.70%
Average volume
442.33K
Volume
442.27K
Open price
$168.32
High today
$170.11
Low today
$165.98
52 Week high
$191.55
52 Week low
$127.85

Globe Life (GL) at a glance

Globe Life (GL) last traded at $169.72, with a market cap of 12.90B, a price-to-earnings ratio of 11.14 and a dividend yield of 0.70%.

Today the stock has traded between $165.98 and $170.11. The current price is 2.3% above the day's low and 0.2% below its high.

Volume so far is 442.27K shares, in line with the average of 442.33K shares a day.

Over the past year Globe Life has ranged from $127.85 to $191.55, and now sits 66% of the way up that range.

The average analyst price target is $199.26, 17.4% above the current price, from 12 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

83%of 12 analyst ratings say Buy
  • Buy83.3%
  • Hold16.7%
  • Sell0.0%
Price target · 17 analystsAvg $199.26
Low
$167.66
Now
$169.72
High
$236.25

GL news

  • Press releasePRNewswire

    Globe Life Inc. Announces Third Quarter 2026 Earnings Release and Conference Call

  • Press releasePRNewswire

    Globe Life Inc. Announces Third Quarter 2026 Earnings Release and Conference Call

  • Press releasePRNewswire

    Did Globe Life Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releasePRNewswire

    Globe Life Announces New Share Repurchase Authorization

  • Press releasePRNewswire

    GLOBE LIFE INC. DECLARES DIVIDEND

  • Press releasePRNewswire

    GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS

  • Press releasePRNewswire

    Globe Life Inc. Announces Second Quarter 2026 Earnings Release and Conference Call

  • Press releasePRNewswire

    Globe Life Inc. Announces Second Quarter 2026 Earnings Release and Conference Call

Similar companies

Companies in the same industry as Globe Life

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.